ABSTRACT The relative intakes of tar, nicotine, and carbon monoxide were estimated in 2455 cigarette smokers, who freely smoked their usual brands of cigarette. The estimates were derived by using an objective index of inhaling based on the measurement of carboxyhaemoglobin divided by the carbon monoxide yield of the cigarettes smoked, after background and carry over carboxyhaemoglobin effects had been allowed for. Separate analyses were performed according to the yield and type (plain, filter, etc) of cigarette smoked. The analyses based on yield indicated that the extent of inhaling was adjusted sufficiently to achieve similar intakes of nicotine/carbon monoxide regardless of the nicotine/carbon monoxide yield. It was not, however, sufficiently increased to achieve a similar intake of tar as the tar yield of the cigarette decreased. The analyses based on type of cigarette indicated that the extent of inhaling was adjusted to achieve similar intakes of tar and nicotine regardless of the type of cigarette smoked, but that this led to a greater intake of carbon monoxide among filter cigarette smokers than that among smokers of plain cigarettes-more so than would have been expected from their relative carbon monoxide yields. Two conclusions arise from these results. Firstly, any harmful effects of nicotine/carbon monoxide are unlikely to be materially reduced by smoking cigarettes with lower yields of nicotine/ carbon monoxide, but the harmful effects of tar are likely to be reduced by smoking cigarettes with lower tar yields. These predictions appear to be borne out by epidemiological observations. Secondly, any harmful effects of carbon monoxide on the cardiovascular system will be greater in smokers of modem filter cigarettes than in smokers of modem plain cigarettes, provided that these two groups of smokers are otherwise similar with respect to risk of cardiovascular disease.
In an earlier paper we described an objective index of inhaled cigarette smoke based on carboxyhaemoglobin concentration and the carbon monoxide yield of the cigarettes smoked.' Smokers of ventilated filter cigarettes were found to inhale 82% more than smokers of plain cigarettes and those who smoked unventilated filter cigarettes 36% more than smokers of plain cigarettes (ventilated cigarettes have perforations in the filter admitting air that dilutes tne mainstream smoke). These differences encouraged us to investigate the matter further and estimate the relative intakes of tar, nicotine, and carbon monoxide from cigarettes of different yields.
We did this in a preliminary way in our previous paper in respect of tar and nicotine intakes according to type of cigarette. Here we have extended the observations to include estimates of carbon monoxide intake and have in addition estimated the relative intakes of tar, nicotine, and carbon monoxide according to the yields of the cigarettes and regardless of cigarette type.
Methods
The study population consisted of men aged 35-64 years who attended the BUPA Medical Centre in London for a comprehensive health screening examination and has been described previously. ' The men were asked about their medical history and their usual and recent smoking habits. All information was collected after arrival at the centre, and the 362 men were not forewarned about the survey of smoking habits. The time when each cigarette, cigar, or pipe had been smoked that day was Relative intakes of tar, nicotine, and carbon monoxide from cigarettes of different yields greater than has hitherto been appreciated. The results also show that the estimated relative intakes of tar, nicotine, and carbon monoxide do not vary greatly with the yield of the cigarette. Only the relative intake of tar declined with declining tar yields. The data also demonstrate an important point in connection with the relative intake of carbon monoxide. When our data are analysed according to the yield of the cigarette the relative intake of carbon monoxide remains fairly constant, but when analysed according to the type of cigarette the relative intake of carbon monoxide is about 60% higher in smokers of filter cigarettes than in smokers of plain cigarettes. This arises largely because, apart from some ventilated cigarettes, filter cigarettes tend to have higher carbon monoxide yields than plain cigarettes. In addition, the smoke from such cigarettes is also inhaled more. This finding does not emerge when the data are analysed according to yield because plain cigarettes during the period of the study represented a very small proportion of the cigarettes smoked.
There are two medical and scientific implications which arise from our results. Firstly, if carbon monoxide or nicotine, or some other constituent of tobacco smoke which is correlated with the yield of these substances, is the cause of the excess risk of heart disease among smokers, smokers of relatively low yield cigarettes would be expected to have about the same excess risk of heart disease as people smoking higher yielding cigarettes. In contrast, the risk of a disease such as lung cancer, which is related to the tar yield of a cigarette, is likely to be lower in smokers of low tar than of high tar cigarettes.
These predictions explain the epidemiological observations on the risk of heart disease and lung cancer in relation to yield and type of cigarette reasonably well. With regard to heart disease, there is a notable recent paper on the risk of myocardial infarction in relation to the nicotine and carbon monoxide yields of cigarettes. The paper showed that there was no significant association between yields of either of these two substances and the risk of disease.3 It is apparent from our findings that this result cannot be taken to exclude the possibility that either nicotine or carbon monoxide may be a cause of myocardial infarction. The result can readily be explained by the fact that in that study smokers of low tar and low nicotine cigarettes compensated for the lower yields by greater inhaling. Other epidemiological studies have shown either no decrease in risk of heart disease45 with decreasing yields or only a modest decrease. 6 So far as lung cancer is concerned, several epidemiological studies have shown that the risk is lower in smokers of low tar cigarettes than in smokers of high tar cigarettes,4 [6] [7] [8] [9] [10] [11] [12] and only one did not. '3 On the basis of the estimated intake of tar the reduction in risk of lung cancer would not be as much as expected from the relative cigarette yields. It is quite plausible, however, that the increase in inhaling results in a tendency for tar to be inhaled beyond the target site, the main bronchi'4; and this in itself may contribute to the reduction in risk of lung cancer associated with smoking low tar cigarettes.
The second implication from our results is that the difference in relative tar and nicotine intakes among smokers of plain and filter cigarettes can be exploited epidemiologically to investigate whether carbon monoxide is a possible cause of coronary heart disease. If carbon monoxide is the principal agent in tobacco smoke responsible for cardiovascular disease the risk of heart disease among smokers of filter cigarettes would be expected to be higher than among smokers of plain cigarettes if the smokers are otherwise similar in respect of factors associated with the risk of heart disease. This is unlikely to be the case, since the sections of the community switching to filter cigarettes first are SIR,-Such scant information as was provided about the pharmacology of this drug by Dr S Lal and others (November 1984;39:809-12) suggested that it had properties similar to those of sodium cromoglycate. It is thus extremely strange, to say the least, that there was no mention of that drug in their article.
The clinical trial it reported was claimed to show that nedocromil sodium was superior to placebo in the management of asthma. Even that simplistic conclusion is, however, open to question because the numbers of patients in the two trial groups were small ( 13 on active drug and 17 on placebo), and no attempt seems to have been made to match them for atropic status, which might well have influenced the response to treatment. As for the results, the three tables show p values for 28 separate comparisons of the effects of nedocromil sodium and placebo, but in no less than 16 there were no significant differences between the two treatments. In the other 12 the differences in favour of the active drug were no more than marginally significant (p <0.05) in 11, leaving only one with a p value of <0.01.
My object in inviting you to publish this letter is, however, not only to criticise some very shaky statistics, but also to ask the authors why the study did not 
